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Abstract
The process of autophagy involves the formation of autophagosomes, double-membrane structures that encapsulate
cytosol. Microtubule-associated protein light chain 3 (LC3) was the first protein shown to specifically label autophagosomal
membranes in mammalian cells, and subsequently EGFP-LC3 has become one of the most widely utilized reporters of
autophagy. Although LC3 is currently thought to function primarily in the cytosol, the site of autophagosome formation,
EGFP-LC3 often appears to be enriched in the nucleoplasm relative to the cytoplasm in published fluorescence images.
However, the nuclear pool of EGFP-LC3 has not been specifically studied in previous reports, and mechanisms by which LC3
shuttles between the cytoplasm and nucleoplasm are currently unknown. In this study, we therefore investigated the
regulation of the nucleo-cytoplasmic distribution of EGFP-LC3 in living cells. By quantitative fluorescence microscopy
analysis, we demonstrate that soluble EGFP-LC3 is indeed enriched in the nucleus relative to the cytoplasm in two
commonly studied cell lines, COS-7 and HeLa. Although LC3 contains a putative nuclear export signal (NES), inhibition of
active nuclear export or mutation of the NES had no effect on the nucleo-cytoplasmic distribution of EGFP-LC3.
Furthermore, FRAP analysis indicates that EGFP-LC3 undergoes limited passive nucleo-cytoplasmic transport under steady
state conditions, and that the diffusional mobility of EGFP-LC3 was substantially slower in the nucleus and cytoplasm than
predicted for a freely diffusing monomer. Induction of autophagy led to a visible decrease in levels of soluble EGFP-LC3
relative to autophagosome-bound protein, but had only modest effects on the nucleo-cytoplasmic ratio or diffusional
mobility of the remaining soluble pools of EGFP-LC3. We conclude that the enrichment of soluble EGFP-LC3 in the nucleus is
maintained independently of active nuclear export or induction of autophagy. Instead, incorporation of soluble EGFP-LC3
into large macromolecular complexes within both the cytoplasm and nucleus may prevent its rapid equilibrium between
the two compartments.
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Introduction
Macroautophagy (hereafter referred to as autophagy) is a
process by which cells degrade intracellular components in order
to buffer against starvation conditions, eliminate aggregated
cytosolic proteins, and turn over organelles [1]. The process of
autophagy involves the formation of double-membrane structures
that encapsulate cytosol. These so-called autophagosomes go on to
fuse with lysosomes, leading to the degradation of their contents
[2].
Microtubule-associated protein light chain 3 (LC3) was the first
protein shown to specifically label autophagosomal membranes in
mammalian cells [3]. EGFP-LC3 has subsequently become widely
used to monitor autophagy by visualizing its recruitment to
autophagosomes [4,5,6,7,8]. The yeast homolog of LC3, Atg8p, is
known to function in the formation of autophagosomes in yeast,
where it plays a role in membrane tethering and hemifusion
during autophagosome formation [9,10]. The association of LC3
and Atg8p with autophagosome membranes requires several post-
translational modifications [3,11]. The proprotein undergoes
cleavage of its C-terminus to form a soluble LC3-I, and is ulti-
mately modified by the attachment of phosphatidylethanolamine
to form membrane bound LC3-II [12,13]. Intra-autophagosomal
LC3-II is subsequently degraded [14,15], whereas cytosolically-
localized LC3-II can be released from the autophagosome
membrane following delipidation [16].
Although LC3 is currently thought to function primarily in the
cytosol, the site of autophagosome formation, EGFP-LC3 is found
in the nucleoplasm as well [17,18,19,20]. In principle, given the
low molecular weight (,18 kDa) of the processed forms of LC3,
the protein could potentially enter the nucleus by passively
diffusing through the nuclear pores even when fused to EGFP, a
27 kDa protein [21]. Interestingly, distinct enrichment of EGFP-
LC3 in the nucleus is apparent upon inspection of fluorescence
images in a number of published studies, suggesting that instead
the entry and exit of the protein may be specifically regulated
[8,17,18,19,20,22]. Moreover, regulation of the nucleo-cytoplas-
mic distribution of proteins is increasingly recognized as a control
point in the autophagy pathway [23,24]. However, the nuclear
pool of EGFP-LC3 has not been specifically studied in previous
reports, and mechanisms by which LC3 shuttles between the
cytoplasm and nucleoplasm are currently unknown.
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regulation of the nucleo-cytoplasmic transport of soluble EGFP-
LC3 using quantitative fluorescence microscopy and photobleach-
ing techniques. We show that soluble EGFP-LC3 is enriched in
the nucleus relative to the cytoplasm and that the maintenance of
its nuclear enrichment is independent of active nuclear export or
induction of autophagy. Instead, our data suggest that incorpo-
ration of soluble EGFP-LC3 into large macromolecular complexes
within both the cytoplasm and nucleus may prevent its rapid
equilibrium between these two subcellular compartments.
Results
EGFP-LC3 and tfLC3 are enriched in the nucleus under
steady state conditions
Fluorescence images of cells expressing EGFP-LC3 often show a
marked enrichment of the protein in the nucleus compared to the
cytoplasm [8,17,18,19,20]. To examine this nuclear enrichment
phenotype in more detail, we transiently expressed two different
tagged versions of LC3, EGFP-LC3 and tfLC3 in COS-7 cells,
and found that both appeared to be enriched in the nucleus
(Figure 1A). To quantify the extent of enrichment of the LC3
fusion proteins in the nucleus, we sampled the average
fluorescence intensity of GFP within regions of interest placed
within the cytoplasm and nucleus from confocal sections and
calculated the nuclear/cytoplasmic ratio for 40–60 cells across 4–5
independent experiments for each protein (Figure 1B). For this
analysis, we only considered regions devoid of punctate structures,
and thus all references to ‘‘cytoplasmic’’ and ‘‘nuclear’’ EGFP-
LC3 refer to the soluble form of the protein. This analysis revealed
that both EGFP-LC3 and tfLC3 are enriched in the nucleus ,1.8
fold. To exclude the possibility that the apparent nuclear
enrichment of GFP-LC3 and tfLC3 is an artifact of imaging, we
examined the subcellular distribution of EGFP, a soluble 27kDa
protein lacking specific targeting information, under identical
conditions. Unlike EGFP-LC3, EGFP was equally distributed
between the nucleoplasm and cytoplasm (Figure 1A). Quantifica-
tion verified that the nuclear/cytoplasmic ratio of EGFP-LC3 was
in fact significantly higher than that of EGFP (Figure 1B). Similar
nuclear enrichment was observed for a mutant of LC3 unable to
undergo C-terminal cleavage and lipid conjugation [3], EGFP-
LC3
G120A (Figure 1D).
We next asked whether enrichment of EGFP-LC3 in the
nucleus is specific to COS-7 cells or instead is a more general
phenotype. To test this, we examined the localization of EGFP-
LC3 in a HeLa cell line stably expressing EGFP-LC3 [18].
Compared to COS-7 cells, a much larger fraction of EGFP-LC3
was constitutively associated with putative autophagosomes in the
cytoplasm of the HeLa cell line (Figure 1C). Nevertheless, similar
to the COS-7 cells, soluble EGFP-LC3 was clearly present at
higher levels in the nucleoplasm than cytoplasm. Thus, the nuclear
enrichment of soluble EGFP-LC3 does not appear to be a cell-type
specific phenomenon. We therefore next considered potential
mechanisms that might regulate the levels of EGFP-LC3 and
tfLC3 in the nucleus.
Coexpression of Atg4B
C74A with EGFP-LC3 shifts EGFP-
LC3 out of the nucleus
One condition that has been previously noted to change the
nucleo-cytoplasmic localization of EGFP-LC3 is co-expression of
a mutant form of Atg4B
C74A, a protease that cleaves the LC3
precursor to produce LC3-I and that catalyzes the delipidation of
LC3 [25]. In particular, the presence of a catalytically inactive
form of Atg4B, mStrawberry-Atg4B
C74A, was shown to lead to
the sequestration of EGFP-LC3 in the cytoplasm and depletion
from the nucleus [25]. When expressed individually in COS-7
cells, mStrawberry-Atg4B
C74A was found predominantly in a
soluble cytoplasmic pool, whereas EGFP-LC3 was distributed in
both the nucleus and cytoplasm (Figure 1E). However, when we
cotransfected COS-7 cells with EGFP-LC3 and mStrawberry-
Atg4B
C74A, a marked shift in the localization of EGFP-LC3 out
of the nucleus and into the cytoplasm was observed (Figure 1F).
These data confirm that the nucleocytoplasmic distribution of
EGFP-LC3 is subject to regulation by protein-protein interactions
in the cytoplasm [25]. We therefore next tested the role of other
mechanisms, such as active nuclear transport, that could
potentially modulate EGFP-LC3’s nucleocytoplasmic distribu-
tion.
LC3 contains a putative NES, but the nucleo-cytoplasmic
distribution of EGFP-LC3 is maintained independently of
active nuclear export
Nucleocytoplasmic transport can be controlled in a variety of
ways including regulation of the nuclear pore complex, transport
receptors, and cargo themselves [21]. One specific mechanism by
which EGFP-LC3 could become enriched in the nucleus is
through regulated nucleocytoplasmic shuttling. Cargo molecules
that are actively transported through the nuclear pore complex
contain signals that are recognized by transport receptors.
Recognition for import into the nucleus is mediated by a nuclear
localization signal (NLS) whereas export is determined by a
nuclear export signal (NES) [21]. We analyzed the sequence of
human microtubule-associated proteins 1A/1B light chain 3A
precursor for NLS and NES sequences. No known NLS sequences
were identified. However, a putative NES was identified using an
algorithm that predicts leucine-rich nuclear export signals [26].
This predicted NES is located at residues 63 to 73 of human LC3
(Figure 2A). The presence of this NES suggests that the nuclear
transport of LC3 may indeed be actively regulated.
As an initial test of whether the transport of EGFP-LC3 out of
the nucleus is actively regulated, we examined the effect of
inhibition of nuclear export. CRM-1 is a protein required for the
nuclear export of proteins containing an NES [27]. Leptomycin B
(LMB) specifically inhibits nuclear export by alkylating CRM-1
[28]. As a positive control for the effect of LMB, we examined the
distribution of a shuttling reporter protein containing a classic
NLS and NES, Rev(68–90)GFP2-cNLS. [29]. In COS-7 cells,
Rev(68–90)GFP2-cNLS had a predominant cytoplasmic distribu-
tion under steady state conditions, suggesting that in this cellular
environment the NES is dominant over the NLS (Figure 2B).
Treatment of COS-7 cells with 20 ng/ml LMB for 3 h [30]
caused a significant accumulation of Rev(68–90)GFP2-cNLS in the
nucleus. In contrast, no change in the nuclear/cytoplasmic ratio of
EGFP-LC3 was observed in the presence of LMB (Figure 2B, C).
LMB treatment similarly had no effect on the subcellular
distribution of EGFP-LC3 in HeLa cells (Figure 2D). This suggests
that maintenance of the steady state localization of EGFP-LC3
does not require active export from the nucleus.
Beclin-1 is known to contain a leucine-rich NES that is
necessary for its function in autophagy [23]. Mutation of the NES
shifts beclin-1 from a primarily cytoplasmic to nuclear localiza-
tion [23]. We used a similar strategy to further test for a role of
active nuclear transport in control of the steady state levels of
EGFP-LC3 in the nucleus versus cytoplasm, by generating a
mutant form of EGFP-LC3 (EGFP-LC3 mNES) in which three
leucines in the putative NES were mutated to alanine (L63A
L71A L73A). Two phenotypes were observed in cells expressing
EGFP-LC3 mNES (Figure 2E). In the majority of cells, the
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plasm (Figure 2E, left panel). In a smaller fraction of cells, the
NES mutant protein was associated with punctate structures in
the cytoplasm, which presumably correspond to autophagosomes
and/or protein aggregates (Figure 2E, right panel). Thus, the
putative NES of LC3 does not functionally direct the protein out
of the nucleus in a CRM-1 dependent fashion under steady state
conditions.
Figure 1. EGFP-LC3 and tfLC3 are selectively enriched in the nucleus under steady state conditions. (A) Localization of EGFP, EGFP-LC3,
and tfLC3 under steady state conditions in transiently transfected COS-7 cells. (B) Quantification of N/C ratios for EGFP, EGFP-LC3, and tfLC3 under
steady state conditions was performed as described in the Materials and Methods. Data show the mean 6 SD for 40–60 cells from a total of 4–5
independent experiments for each protein. **, p,.0001 compared to EGFP by Student t-test. (C) Distribution of EGFP-LC3 in stably transfected HeLa
cells. (D) (Left) Subcellular distribution of EGFP-LC3 versus EGFP-LC3
G120A in COS-7 cells. (Right) Mean N/C ratios were measured for 58-79 cells from 4
independent experiments. (E) (Left) Localization of mStrawberry-Atg4B
C74A versus EGFP-LC3 when expressed individually in COS-7 cells. (Right) Mean
N/C ratios were obtained from 56–61 cells from 3 independent experiments. **, p,.0001 compared to mStrawberry-Atg4B
C74A by Student t-test. (F)
Localization of mStrawberry-Atg4B
C74A (red in merged image) and EGFP-LC3 (green in merged image) following their coexpression in COS-7 cells. All
scale bars =10 mm.
doi:10.1371/journal.pone.0009806.g001
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microtubule disruption
LC3 is a microtubule binding protein [31], and autophago-
some formation and dynamics are also known to be microtubule
dependent [20]. We therefore asked whether the nucleo-
cytoplasmic distribution of EGFP-LC3 requires intact microtu-
bules. To test this, we utilized nocodazole (NZ) treatment to
disrupt microtubules [32]. Under these conditions, in COS-7 cells
the distribution of EGFP-LC3 was unaltered compared to cells
subjected to mock NZ treatment (Figure 3A,B). In HeLa cells, NZ
treatment resulted in a visible increase in the number and
fluorescence intensity of EGFP-LC3 puncta in the cytoplasm
(Figure 3C). Image analysis showed that the soluble pool of
protein had a lower N/C ratio in NZ-treated cells than mock-
treated cells (Figure 3D). Therefore, in HeLa cells, microtubule
disruption influences the N/C ratio of EGFP-LC3, but do not
appear to be required to maintain a pool of EGFP-LC3 within
the nucleus.
EGFP-LC3 is transported into and out of the nucleus at a
very slow rate
Although EGFP-LC3 does not appear to undergo actively
regulated or induced transport, it is still possible that the protein
moves across the nuclear envelope by passive diffusion. To
determine if this is the case, we used FRAP to determine the
kinetics of EGFP-LC3’s nucleocytoplasmic transport [30,33,34].
For these experiments, we used a confocal microscope to
selectively photobleach the fluorescent protein in the nucleus or
cytoplasm by repetitively scanning the region using 100% laser
power. A series of images was then collected over time using low
laser illumination in order to monitor recovery of the fluorescent
protein into the bleached region (Figure 4). For comparison, we
measured the transport kinetics of EGFP as an example of a
protein that undergoes passive diffusion through nuclear pores
[35].
Photobleaching measurements of nuclear import revealed that
EGFP equilibrated to its original distribution within 5 min
(Figure 4A). This is consistent with the ability of EGFP to diffuse
passively through nuclear pores [30,36]. However, recovery of
EGFP-LC3 into the nucleus occurred considerably more slowly
than that of EGFP (Figure 4A). The nuclear export rate of EGFP-
LC3, measured by photobleaching the cytoplasmic pool of the
protein, was also markedly slower than that of EGFP (Figure 4B).
Similar results were obtained for tfLC3 (Figure 4A, B). Recovery
of EGFP-LC3 in the nucleus was visible within 300 s, but still had
not returned to steady state values in the stable EGFP-LC3
expressing HeLa cell line (Figure 4C). Thus, transport of the LC3
fusion proteins into and out of the nucleus occurs more slowly that
than of EGFP under steady state conditions, ruling out a model in
which rapid passive transport contributes significantly to its steady
state distribution.
Figure 2. LC3 contains a putative NES, but remains enriched in the nucleus following blockade of nuclear export or mutation of the
NES. (A) Sequence of human LC3. The predicted leucine-rich nuclear export signal is underlined. (B) Effect of LMB, a specific inhibitor of nuclear
export, on the distribution of EGFP-LC3 or Rev(68–90)GFP2-cNLS. COS-7 cells expressing EGFP-LC3 or Rev(68–90)GFP2-cNLS were treated with 20 nM
LMB for 3 h at 37uC. The cells were then shifted onto the microscope stage for imaging. Scale bar =10 mm. (C) Quantification of the mean intensity of
EGFP-LC3 and Rev(68–90)GFP2-cNLS in the nucleoplasm versus the cytoplasm of COS-7 cells under control conditions and following LMB treatment.
Data show the mean 6 SD for 20 cells from 2 independent experiments. **, p,.0001 compared to control by Student t-test. (D) Distribution of EGFP-
LC3 in stably transfected HeLa cells following treatment with 20 nM LMB or vehicle for 3 h at 37uC. Scale bar =10 mm. (E) Distribution of EGFP-LC3
mNES mutant in COS-7 cells. Representative images showing the two major phenotypes observed are shown. Scale bars =10 mm.
doi:10.1371/journal.pone.0009806.g002
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cytoplasm suggests it undergoes transient binding
events and/or associates with a high molecular weight
complex
We next considered possible mechanisms that could account for
the impeded movement of EGFP-LC3 and tfLC3 into and out of
the nucleus. The transport of some proteins between the cytoplasm
and nucleus is controlled by interactions with binding partners in
each compartment rather than active transport across the nuclear
pore [34,36]. The diffusional mobility of proteins can be used to
test whether they interact with cellular components such as
chromatin or diffuse as part of a high molecular weight complex
[37,38]. To test whether this is the case for EGFP-LC3 and tfLC3,
we used fluorescence recovery after photobleaching (FRAP) to
measure the diffusional mobility of the protein within the nucleus
and cytoplasm [39,40,41]. In these experiments, a confocal
microscope was used to monitor the fluorescence intensity in a
small region of interest (ROI) within the nucleus or cytoplasm
before and after irreversibly photobleaching the molecules within
the ROI by repetitively scanning at 100% laser power. Following
the photobleach, non-fluorescent molecules within the ROI
exchange with fluorescent molecules in the surrounding area by
diffusion. Note that this experiment differs from the measurement
of nuclear import described above in that only a small region is
bleached within the nucleus. Thus, fluorescence recovery occurs
by lateral diffusion and not transport across the nuclear
membrane, which occurs over longer times than the characteristic
time of diffusional recovery.
FRAP data can be characterized by two parameters, an
apparent diffusion coefficient (D) which provides a measure of
the mean squared displacement of the diffusing molecule per unit
time, and a mobile fraction (Mf) a measure of the fraction of
molecules that are free to diffuse over the time course of the
experiment [37]. In such experiments, monomeric proteins that do
not interact with any cellular components, such as EGFP [42,43],
should have a high mobile fraction and a diffusion coefficient
consistent with their size and shape. For such molecules, D can be
directly calculated according to the Stokes-Einstein equation, D =
(kBT)/(6pgr), where kB is the Boltzmann constant, T absolute
temperature, g the viscosity, and r the Stokes radius of the
diffusing molecule. In contrast, proteins that transiently bind
cellular structures or that diffuse as part of a large complex will
diffuse more slowly than predicted for their size and shape [38,42].
For example, the diffusion of transcription factors is slowed by
transient binding to DNA [42,44]. Finally, proteins that are tightly
bound to immobile structures such as chromatin are predicted to
have a slow diffusion coefficient and/or low mobile fraction
compared to a freely diffusing soluble protein such as EGFP. Such
behavior has been observed for histone 2B [45].
To analyze the diffusional mobility of EGFP-LC3 and tfLC3,
we bleached a small circular region of interest located either in the
nucleoplasm or the cytoplasm, and imaged the bleach ROI and
the area immediately surrounding it during the recovery (Figure 5).
The resulting recovery curves were then fit with a model that
corrects for diffusion during the bleach as described in the
Materials and Methods [46]. As controls, we performed parallel
experiments for EGFP and p53-GFP, a protein that transiently
binds to DNA [42,44]. Because EGFP-LC3 is only ,20 kDa
larger than EGFP, its D should be quite similar to that of EGFP if
it behaves as a freely diffusing monomer. In contrast, we found
that D for both EGFP-LC3 and tfLC3 in the nucleus was
substantially slower than that of EGFP, but faster than that of p53-
GFP (Figure 5C, D). In the cytoplasm, D of EGFP-LC3 and tfLC3
was again significantly (,3 fold) slower than that of EGFP
(Figure 5B, D). Moreover, D’s for EGFP-LC3 and tfLC3 diffusion
were similar to one another in both the nucleus and cytoplasm of
COS-7 cells (Figure 5). In addition, Mf of EGFP-LC3 and tfLC3
were nearly as high as for EGFP, suggesting that LC3 is not stably
bound to immobile structures within the cell (Figure 5E).
To determine whether the slow diffusion of EGFP-LC3 was an
artifact of its overexpression in COS-7 cells, we repeated the FRAP
experiments in the stable EGFP-LC3 expressing HeLa cell line. As
for the case of COS-7 cells, we observed that D for EGFP-LC3 was
slower than expected for a monomeric protein of its molecular
weight. However, in HeLa cells we also observed a significantly
higher value of D in the nucleus (4.560.3 mm
2/s, N=30 cells from 3
Figure 3. The nucleocytoplasmic distribution of EGFP-LC3 is modestly affected by microtubule disruption. Cells were subjected to
microtubule disruption with 5 mg/ml NZ or mock-treated (‘‘control’’) and fixed prior to imaging as described in the Materials and Methods. (A) Effect
of NZ on the distribution of EGFP-LC3 in COS-7 cells. (B) Quantification of N/C for soluble EGFP-LC3 in mock-treated or NZ-treated COS-7 cells. Data
show the mean 6 SD for 28–30 cells from 2 independent experiments. (C) Effect of NZ on the distribution of GFP-LC3 in HeLa cells. (D) As in B except
data are for EGFP-LC3 in HeLa cells. Data show the mean 6 SD for 62–72 cells from 2 independent experiments. Scale bar =10 mm.
doi:10.1371/journal.pone.0009806.g003
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2/s, N=21
cells from 3 independent experiments). The Mf for nuclear and
cytoplasmic EGFP-LC3were identical in the HeLa cells(0.7760.06).
Taken together, these FRAP data suggest that EGFP-LC3 does
not exist as a freely diffusing monomer in either the cytoplasm or
nucleoplasm, but rather is either incorporated into a macromo-
lecular complex or reversibly binds cellular components.
Analysis of the nuclear/cytoplasmic distribution and
diffusion of EGFP-LC3 following induction of autophagy
The finding that EGFP-LC3 and tfLC3 are enriched in the
nucleus under steady state conditions additionally raises the
question of whether their nuclear-cytoplasmic distribution is
physiologically regulated. To test this, we examined the distribu-
tion of EGFP-LC3 and tfLC3 during the induction of autophagy
Figure 4. The kinetics of nuclear import and export of EGFP-LC3 and tfLC3 are significantly slower that that of EGFP as assessed
by photobleaching. Photobleaching experiments of the entire nucleus or entire cytoplasm were performed at 37uC. (A) Images from a representative
nuclear photobleaching experiment measuring the kinetics of nuclear import of EGFP-LC3, tfLC3, and EGFP in COS-7 cells. (B)A si nA ,e x c e p tt h ec y t o p l a s -
mic pool of proteins were photobleached. (C) Images from a representative nuclear photobleaching experiment of EGFP-LC3 in HeLa cells. Bars, 10 mm.
doi:10.1371/journal.pone.0009806.g004
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[14], with increasing time of starvation the number of soluble
EGFP-LC3 and tfLC3-positive putative autophagosomes in-
creased in both COS-7 (Figure 6A) and HeLa cells (Figure 6D).
In HeLa cells, the amount of EGFP-LC3 associated with
autophagosomes also increased relative to the levels of soluble
protein (Figure 6D; note the decreased diffuse fluorescence relative
to the punctate staining at 5 h and 5 h relative to control.)
We next quantified the fluorescence levels of soluble EGFP-LC3
from regions of interest placed within in the cytoplasm and
nucleoplasm to assess the nucleo/cytoplasmic ratio. In COS-7 cells,
the nuclear-cytoplasmic ratio of soluble EGFP-LC3 and tfLC3
remained identical within error to control values, even after 5 h of
nutrient starvation (Figure 6B). In contrast, in the stable HeLa cell
line, soluble EGFP-LC3 showed a transient increase in nuclear-
cytoplasmic ratiofollowing1 h ofamino acid starvationin2 out of3
experiments (Figure 6D, E). When autophagy was induced by
rapamycin treatment of HeLa cells, the number and brightness of
autophagosomes again increased as reported by EGFP-LC3
labeling (Figure 7A). Quantitative analysis of multiple cells indicated
that the nucleo-cytoplasmic levels of soluble EGFP-LC3 remained
steady compared to controls following rapamycin treatment
(Figure 7B). Thus, the induction of autophagy led to a small,
transient increase in the levels of soluble EGFP-LC3 in the nucleus
versus cytoplasm of HeLa cells at early times following upregulation
of autophagy by starvation, but not by rapamycin treatment.
We also wondered if the diffusional mobility of EGFP-LC3
within the nucleus or cytoplasm is altered by upregulation of
autophagy. To test this, we performed FRAP experiments of the
nuclear and cytoplasmic pools of soluble EGFP-LC3 in COS-7
cells under control conditions and following 5 h of amino acid
starvation. The resulting recovery curves were very similar for
control and starved cells (Figure 6C). We repeated this analysis in
the HeLa cells, but in this case restricted our analysis to nuclear
protein as the large number of autophagosomes in the cytoplasm
interfered with the FRAP experiments. Interestingly, D for EGFP-
LC3 in the nucleus of HeLa cells underwent a small but significant
decrease as a function of starvation time (Figure 6F). This implies
that the same mechanisms that retard the lateral mobility of
EGFP-LC3 in the nucleus under steady state conditions are
preserved and/or even further upregulated when autophagy is
induced by amino acid starvation.
Endogenous LC3 can also be detected in both the
nucleus and cytoplasm under steady state conditions
In the experiments described above, we focused exclusively on
the properties of GFP-tagged versions of LC3. There is currently
Figure 5. EGFP-LC3 and tfLC3 diffuse more slowly than predicted by their molecular weights. COS-7 cells were transfected with the
indicated constructs. The following day, confocal FRAP experiments were performed at 37uC as described in the Materials and Methods. (A)
Representative images collected during a FRAP experiment in COS-7 cells. Data are shown for measurements in the nucleus. Scale bar =2 mm. (B)
Recovery curves for EGFP (black circles), EGFP-LC3 (blue squares), and tfLC3 (red triangles) in the cytoplasm of COS-7 cells. Data show the mean
values for 10 cells from a representative experiment. For clarity, error bars are not shown. (C) Recovery curves for EGFP (black circles), EGFP-LC3 (blue
squares), and p53-GFP (green crosses) in the nucleus of COS-7 cells. Data show the mean 6 SE for 10 cells from a representative experiment. For
clarity, error bars are not shown. (D) Effective diffusion coefficients for EGFP, EGFP-LC3, tfLC3, and p53-GFP in the cytosol (white bars) and nucleus
(gray bars) of COS-7 cells. Data show the mean 6 SD for 30 cells from a total of 3 independent experiments. (E) Mobile fractions for EGFP, EGFP-LC3,
tfLC3, and p53-GFP in the cytosol (white bars) and nucleus (gray bars) of COS-7 cells. Data show the mean 6 SD for 30 cells from a total of 3
independent experiments.
doi:10.1371/journal.pone.0009806.g005
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PLoS ONE | www.plosone.org 7 March 2010 | Volume 5 | Issue 3 | e9806Figure 6. Effect of amino acid starvation on the nuclear/cytoplasmic ratio and diffusional mobility of EGFP-LC3. (A) Effect of amino
acid starvation on the subcellular localization of EGFP-LC3, tfLC3, and EGFP in live COS-7 cells. Bar, 10 mm. (B) Quantification of the mean intensity of
EGFP, EGFP-LC3, and tfLC3 in the nucleoplasm versus the cytoplasm under control conditions and following amino acid starvation in COS-7 cells. Data
show the mean 6 SD for 20-30 cells from 2–3 independent experiments for each protein. (C) Representative FRAP curve for EGFP-LC3 in the
cytoplasm or nucleus of untreated COS-7 cells (‘‘control’’, open squares) and COS-7 cells incubated for 5 h in EBSS (‘‘starved’’, closed circles). FRAP
Nuclear Dynamics of LC3
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nucleus in addition to the cytoplasm [47,48]. However, some
previous immunofluorescence studies of endogenous LC3 utilized
digitonin permeabilization, a condition that preferentially per-
meabilizes the plasma membrane while leaving the nuclear
envelope intact [49]. As a result, the presence of LC3 in the
nucleus could have previously gone undetected. We therefore
examined the distribution of endogenous LC3 in COS-7 cells by
immunofluorescence microscopy.
To validate conditions that enable detection of LC3 in the
nucleus, we first immunostained cells expressing EGFP-LC3
(Figure 8). In saponin permeabilized cells, labeling by the anti-
LC3 antibody was confined to the cytoplasm, despite the presence
of EGFP-LC3 in the nucleus (Figure 8A). This was not due to
masking of the epitope detected by the LC3 antibody in the
nucleus, as similar results were obtained using a GFP antibody
(Figure 8B). We therefore expanded the fixation and permeabi-
lization conditions to determine under what conditions nuclear
EGFP-LC3 could be detected, and found PFA/TX-100 permea-
bilization allowed for visualization of both cytoplasmic and nuclear
EGFP-LC3 (Figure 8C).
Having established conditions to detect both nuclear and
cytoplasmic staining of exogenous EGFP-LC3 by immunofluores-
cence microscopy, we next evaluated the localization of endoge-
nous LC3 in COS-7 cells. In cells subjected to PFA/TX-100
fixation and permeabilization, staining of endogenous LC3 was
observed in both the cytoplasm and nucleus (Figure 8D). Thus, like
Figure 7. Effect of rapamycin on the nucleo-cytoplasmic
distribution of EGFP-LC3. (A) Effect of rapamycin treatment or
incubation with vehicle (control) on the distribution of EGFP-LC3 in
fixed HeLa cells. Bar, 10 mm. (B) Quantification of the N/C ratio of EGFP-
LC3 following rapamycin treatment versus treatment with vehicle
(control) in fixed HeLa cells. To correct for differences in basal N/C
values across experiments, data for rapamycin treated cells were
normalized to control values for a given experiment. Data represent the
mean 6 SD for 98–113 cells from 3 independent experiments.
doi:10.1371/journal.pone.0009806.g007
Figure 8. Detection of exogenous and endogenous LC3 in the
nucleoplasm by immunostaining. (A) COS-7 cells expressing EGFP-
LC3 were fixed in 3.7% PFA, permeabilized with 0.1% saponin, and
processed for immunostaining for LC3 as described in the Materials and
Methods. In the merged images, GFP fluorescence is shown in green
and antibody staining in red. (B) As in (A), except cells were labeled with
an anti-GFP antibody. (C) COS-7 cells expressing EGFP-LC3 were fixed in
PFA and permeabilized with TX-100, and stained for LC3 as described in
the Materials and Methods. In the merged images, GFP fluorescence is
shown in green and antibody staining in red. (D) Untransfected COS-7
cells were fixed and permeabilized using saponin or TX-100 as
described in the Materials and Methods and then immunostained for
endogenous LC3. Bars, 10 mm.
doi:10.1371/journal.pone.0009806.g008
experiments were performed as described in the Materials and Methods. Data show the mean6 SD for 8–10 cells from a representative experiment.
For clarity, error bars are only shown for every third datapoint after the bleach. (D) Effect of amino acid starvation on the localization of EGFP-LC3 in
live HeLa cells. Bar, 10 mm. (E) Quantification of the N/C ratio of EGFP-LC3 under control conditions and following amino acid starvation in live HeLa
cells. Data show the mean 6 SD for 81–117 cells from 3 independent experiments. (F) Effective diffusion coefficients for nuclear EGFP-LC3 in HeLa
cells under control conditions or following amino acid starvation. Data show the mean 6 SD for 20–30 cells from 3 independent experiments. *,
p,.01 compared to control, and **, p,.0006 compared to control by Student t-test.
doi:10.1371/journal.pone.0009806.g006
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nucleus under steady state conditions.
Discussion
Mechanisms involved in controlling the nucleo-
cytoplasmic distribution of EGFP-LC3
Although EGFP-LC3 is a marker of autophagosomes, a
substantial fraction of the protein is often present in the nucleus
as well [17,18,19,20,22]. Moreover, levels of soluble EGFP-LC3 in
the nucleus often appear higher than levels of soluble EGFP-LC3
in the cytosol, suggesting that the protein does not simply passively
equilibrate across the nuclear envelope. In the current study, we
therefore investigated how the nucleo-cytoplasmic transport of
EGFP-LC3 from the nucleus is regulated.
We first verified that, consistent with published images, soluble
EGFP-LC3 indeed is enriched in the nucleoplasm relative to the
cytoplasm in two cell types, transiently transfected COS-7 and
stably transfected HeLa, as assessed by quantitative fluorescence
microscopy. In addition, we confirmed recently published findings
that EGFP-LC3 is sequestered in the cytoplasm by coexpression of
a mutant form of Atg4B, a protease that cleaves the LC3 precursor
to produce LC3-I and that catalyzes the delipidation of LC3 [25].
Indeed, of all the conditions we examined, only coexpression of
mStrawberry-Atg4B
C74A and EGFP-LC3, resulted in a complete
loss of EGFP-LC3 from the nucleus. Thus, protein-protein
interactions represent one mechanism that controls the nucleocy-
toplasmic distribution of EGFP-LC3.
Since LC3 is a microtubule binding protein, we next tested
whether intact microtubules are required to maintain the
nucleocytoplasmic distribution of soluble EGFP-LC3. We found
that microtubule disruption with NZ had little effect on the
localization of the protein in COS-7 cells, but modestly decreased
the nucleo-cytoplasmic ratio of the protein in HeLa cells, perhaps
due to increased association of the protein with autophagosomes
under these conditions as discussed in more detail below.
We next tested whether active transport plays a role in
regulating LC3’s steady state distribution. We identified a
predicted leucine-rich NES within residues 63–73, a stretch of
residues contained with the third alpha helix of LC3 as determined
by both x-ray crystallography and NMR [50,51]. We predicted
that if the NES is active under steady state conditions, then
inhibition of active nuclear export or disruption of the NES should
cause EGFP-LC3 to become further enriched in the nucleus
compared to the wild type protein. However, when we treated
cells with LMB, an inhibitor of nuclear export, we found that this
had essentially no effect on the subcellular distribution of EGFP-
LC3 in either COS-7 or HeLa cells. Moreover, when we mutated
the putative NES of LC3, EGFP-LC3 mNES was still found in
both the cytoplasm and nucleus, a result inconsistent with a
functional role of the NES. However, we also noted a second
phenotype, in which the NES mutant was contained within
punctate structures in the cytoplasm, presumably corresponding to
autophagosomes or aggregates of LC3. Importantly, this pheno-
type was never observed in cells expressing wild type EGFP-LC3.
This suggests that the region of the protein containing the putative
NES, which is part of the ubiquitin fold of LC3, is important in
regulation of the interactions of LC3 with other proteins or
autophagosomes themselves.
Interestingly, beclin-1 contains an NES that, unlike that of LC3,
is sensitive to inhibition of CRM-1 dependent transport by LMB
treatment or mutation. Importantly, beclin-1’s NES is also
required for the protein’s function in autophagy as well as its
tumor suppressor activity [23]. Although our current studies did
not reveal a specific function of LC3’s putative NES in nuclear
export, it is possible that the NES is active under other conditions
not investigated here. The role of this presumed NES could be
specific to the function of LC3, as analysis of the sequences of
Atg8, GABA(A) receptor-associated protein (GABARAP) or Golgi-
associated ATPase enhancer of 16 kDa (GATE-16) do not yield a
predicted NES in this region for any of these LC3-related proteins.
Despite the presence of a putative NES, LC3 does not contain a
known NLS. LC3 could potentially harbor an as-yet unidentified
NLS, or alternatively, its nuclear import could be mediated
through an interaction with a protein containing an NLS.
Nucleocytoplasmic transport can occur by passive as well as
active processes. We tested for passive transport by examining the
rate of nucleocytoplasmic shuttling of EGFP-LC3 using a
photobleaching assay. The results of these experiments revealed
that compared to the rapid exchange of EGFP across the nuclear
envelope, the rates of nuclear import and export of EGFP-LC3 are
relatively slow. This suggests that an inhibitory mechanism may
actually trap the protein in the nuclear and cytoplasmic
compartments and prevent passive diffusion across the nuclear
envelope. This could readily be accomplished if EGFP-LC3
formed a small oligomer or protein complex with a molecular
weight of .60 kDa. Our observation that the diffusional mobility
of EGFP-LC3 is nearly threefold slower than that of EGFP, as
discussed further below, is consistent with this model. The ability
of mutant Atg4B to sequester EGFP-LC3 in the cytoplasm [25], a
finding confirmed here, may also reflect such a mechanism.
Our data do not fully rule out the possibility that the attachment
of EGFP to LC3 alters the normal regulation of its nucleo-
cytoplasmic transport, as attachment of a GFP tag has been noted
to alter the nucleo-cytoplasmic distribution of other proteins [52].
However, EGFP itself lacks any nuclear import or export signals,
and under the conditions of our experiments this protein alone is
evenly distributed between the nucleus and cytoplasm. It is thus
highly unlikely that the attachment of EGFP to LC3 could
artificially cause LC3 to accumulate in the nucleus. Indeed, we
could also detect endogenous LC3 in the nucleoplasm by
immunofluorescence microscopy. Although at least one previous
study has detected LC3-II in the nucleus by biochemical
fractionation approaches [47], the nature of endogenous nuclear
LC3 remains to be more fully investigated. Our current studies
highlight the likelihood that this is not an artifact, but rather
reflects the presence of a functional nuclear pool of LC3 in cells.
Biological significance of the slow diffusional mobility of
EGFP-LC3
The finding that the diffusional mobility of EGFP-LC3 in both
the nucleus and cytoplasm is significantly slower than expected for
a protein of its molecular weight can be explained by one of two
possible models. The first model is that the protein undergoes
transient binding events to cellular structures. This type of
behavior has been best described for the case of nuclear proteins,
which often showed slowed diffusion as the result of transient
binding to DNA [42,44]. Although to our knowledge LC3 has not
been previously shown to interact with DNA, the slow diffusion of
the protein in the nucleus could potentially indicate that this
occurs. Similarly, the slower-than-expected diffusion of EGFP-
LC3 in the cytosol could potentially be explained if EGFP-LC3
undergoes rapidly reversible binding to microtubules. However, a
prediction of this ‘‘reversible binding’’ model is that a fraction of
EGFP-LC3 should be visualized in its bound state on these
structures, yet cytosolic EGFP-LC3 and tfLC3 appeared predom-
inantly soluble (other than that bound to autophagosomes).
Furthermore, it seems unlikely that binding of LC3 to different
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coincidentally yield such similar D’s in the two compartments.
We thus favor a model in which EGFP-LC3 diffusion is slowed
by its incorporation into macromolecular complexes in both the
cytoplasm and nucleoplasm and that incorporation of the protein
into these complexes prevents its rapid equilibrium across the
nuclear envelope. Based on the Stokes-Einstein equation, the size
of such complexes would be approximately 950 kDa in order to
account for the 3-fold drop in D of EGFP-LC3 compared to EGFP
in COS-7 cells. Although we do not yet know the identity of the
components of these complexes, a number of candidates exist. For
example the formation of LC3-II was shown to give rise to
multimers [10]. Furthermore, LC3 also has several known binding
partners, including human homologs of Atg7 and Atg3 [53,54]. In
addition, the Atg16L complex, an ,800 kDa complex consisting
of Atg16L and Atg12 conjugated to Atg5, determines the site at
which LC3 lipidation occurs [55]. Interactions of LC3 with other
proteins such as SOS1 have also been reported [56]. LC3 has also
been reported to associate with the 39 untranslated region of
fibronectin mRNA and the 60S ribosomal subunit [57]. Very
recently, LC3 was also shown to interact with a protein related to
tumor protein 53-inducing nuclear protein 1 named TP53INP2
[24]. Normally a nuclear protein, TP53INP2 translocates to
autophagosomes after rapamycin treatment or nutrient depriva-
tion and is required for autophagy. Interestingly, studies using
bioluminescence resonance energy transfer indicate that LC3 and
TP53INP2 interact not only following induction of autophagy by
starvation, but also to a lesser extent under steady state conditions
when TP53INP2 is found primarily in the nucleus. Discerning
which if any of these interactions accounts for the relatively slow
diffusion of EGFP-LC3, and whether such complexes also account
for the slow transport of EGFP-LC3 between the nucleus and
cytoplasm will be an important goal for future studies.
What is LC3 doing in the nucleus?
There is growing evidence that nucleocytoplasmic shuttling of
proteins in the autophagy pathway contributes to the regulation of
this process [23,24]. We tested here whether upregulation of
autophagy by amino acid starvation or rapamycin could be a
physiological trigger of the transport of EGFP-LC3 out of the
nucleus. In some published images of EGFP-LC3 in starved cells,
the protein appears to remain enriched in the nucleus [20,22],
while others demonstrate a marked decrease in nuclear levels
following starvation [18,19]. We found that in both COS-7 and
HeLa cells, soluble EGFP-LC3 remained enriched in the nucleus
relative to the cytoplasm following upregulation of autophagy.
Thus, induction of autophagy does not appear to specifically signal
EGFP-LC3 to either exit or enter the nucleus en masse. However, in
HeLa cells, the presence of soluble protein in either the nucleus or
cytoplasm became progressively less obvious as the levels of EGFP-
LC3 associated with autophagosomes following starvation in-
creased. We speculate that the slow movement of EGFP-LC3
between the nucleus and cytoplasm reported by our photobleach-
ing measurements is sufficient to allow for mass action to drive a
steady loss of the protein from the nucleoplasm as the cytoplasmic
pool of protein is incorporated into autophagosomes. Interestingly,
we also observed a small, transient increase in nucleocytoplasmic
ratio following amino acid starvation in HeLa cells, as well as a
small but significant decrease in D for nuclear EGFP-LC3 after
longer times of starvation. The physiological basis for these
changes is not yet clear, but could reflect time-dependent changes
in the interactions of LC3 with nuclear components, such as the
putative complexes discussed above.
Although recent studies have focused on the role of LC3 in
autophagy, other cellular functions of the protein have also been
postulated. Originally identified as a microtubule associated
protein [31], LC3 has also been shown to play a role in regulating
the levels of fibronectin mRNA [57,58]. In addition, LC3 interacts
with SOS1, a guanine nucleotide exchange factor, leading to
negative regulation of SOS1-dependent Rac1 activation of
membrane ruffling [56]. The dendrite-specific Ca2+ sensing
protein caldendrin has been identified as an LC3 interacting
protein [59]. It will thus be of interest to determine in future
studies which, if any of these functions involve a nuclear form of
LC3.
Materials and Methods
Constructs
The plasmids encoding EGFP-LC3, tfLC3, EGFP-LC3
G120A,
and mStrawberry-Atg4B
C74A were the kind gift of Dr. Tamotsu
Yoshimori, Osaka University [3,14,25]. The plasmid for EGFP
was from Clontech. p53-EGFP was as previously described [42].
The Rev(68–90)GFP2-cNLS construct was the kind gift of Dr.
Ralph Kehlenbach, Universita ¨t Go ¨ttingen [29]. Rev(68-90)GFP2-
cNLS consists of the classic importin a/b-dependent NLS from
SV40, two copies of EGFP, and the CRM1-dependent NES
(residues 68–90) of HIV-1-Rev protein.
An NES mutant of LC3 (L63A L71A L73A), designated here as
EGFP-LC3 mNES, was generated using a Quik Change site-
directed mutagenesis kit (Stratagene, Inc.). Primers used to mutate
amino acid 63 from a Leucine to an Alanine were 59 C GTG AAT
ATG AGC GAA GCC ATC AAG ATA ATT AGA AGG CGC
39(forward) and 59GCG CCT TCT AAT TAT CTT GAT GGC
TTC GCT CAT ATT CAC G 39 (reverse). This mutant was
subject to further mutagenesis of amino acids 71 and 73 from
Leucine to Alanine using the following primers; 59 G ATA ATT
AGA AGG CGC GCG CAG GCC AAT GCT AAC CAA GCC
TTC 39 (forward) and 59 GAA GGC TTG GTT AGC ATT
GGC CTG CGC GCG CCT TCT AAT TAT C 39. All
constructs were verified by sequencing using the CMV forward
sequencing primer 59CGC AAA TGG GCG GTA GGC GTG T
39 by the Vanderbilt Sequencing Core.
Cells and transfections
COS-7 cells were obtained from ATCC and maintained in
DMEM supplemented with 10% fetal calf serum at 37uC and 5%
CO2. For all experiments, cells were plated on coverslips two days
prior to the experiment. Where indicated, the day prior to an
experiment, cells were transfected using FuGene6 (Roche
Diagnostics, Indianapolis) as recommended by the manufacturer.
A HeLa cell line stably expressing EGFP-LC3 [18] was generously
provided by Dr. Aviva M Tolkovsky, Cambridge Centre for Brain
Repair. HeLa cells were maintained in RPMI supplemented with
10% fetal calf serum at 37uC and 5% CO2 and were plated on
coverslips one to two days prior to experiments.
Analysis of NES and NLS signals
Predicted NLS signals were screened using (http://cubic.bioc.
columbia.edu/db/NLSdb/). An algorithm that predicts leucine-
rich nuclear export signals was used to screen for predicted NES
[26].
Drug treatments and induction of autophagy
To inhibit active nuclear transport, cells were incubated in
culture media containing 20 ng/ml leptomycin B (Sigma-Aldrich).
To disrupt microtubules, cells were preincubated for 5 minutes on
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50 mM HEPES. 5 mg/ml of nocodazole (NZ) (Sigma-Aldrich) was
added and the cells were incubated for an additional 15 minutes
on ice. They were then shifted to 37uC for 1 h in the continued
presence of NZ, and either fixed or imaged live in the continued
presence of NZ at 37uC [32]. Control experiments were
performed using vehicle alone (DMSO). For starvation experi-
ments, cells were washed 3 times with Earle’s Balanced salt
solution (EBSS) (Sigma-Aldrich). They were then incubated for the
indicated times in EBSS at 37uC prior to imaging in the continued
presence of EBSS. Rapamycin (Ready Made Solution, Sigma-
Aldrich) was added to phenol red-free DMEM containing 10%
fetal calf serum and 50 mM HEPES to a final concentration of
0.2 mM and cells were incubated at 37uC for 2, 4, or 6 h. As a
control, cells were incubated with media containing an equivalent
volume of vehicle (DMSO) for 6 h. Fixed cells were mounted using
Fluoromount G supplemented with 25 mg/ml DABCO (1,4
diazabicyclo[2.2.2]octane) (Sigma-Aldrich) and allowed to solidify
overnight prior to imaging.
Immunofluorescence staining
A rabbit antibody against recombinant human LC3B (residues
1–120) was from Medical & Biological Laboratories Co, Ltd,
(Nagoya, Japan). Mouse anti-GFP was from Invitrogen Molecular
Probes (Carlsbad, CA). Fluorescently labeled secondary antibodies
were purchased from Jackson ImmunoResearch Laboratories Inc.
(West Grove, PA).
Cells were fixed in 3.7% PFA for 15 min at RT followed by
permeabilization with either PBS containing 10% FCS and 0.1%
saponin for 30 min or 0.1% ice-cold TX-100 in PBS for 5 min on
ice. After blocking they were then incubated with primary
antibodies (1:200 dilution) for 30 min at RT. Cells were then
washed, incubated with 1 mg/ml Cy3 anti-mouse or anti-rabbit
secondary antibodies (Jackson ImmunoResearch Laboratories) for
30 min at RT, and washed again. Coverslips were then mounted
on slides using Fluoromount G supplemented with 25 mg/ml
DABCO (1,4 diazabicyclo[2.2.2]octane) (Sigma-Aldrich) and
allowed to solidify overnight prior to imaging.
Confocal microscopy and photobleaching experiments
Fluorescence images were obtained using a Zeiss LSM 510
confocal (Carl Zeiss, Thornwood, NY). Images were collected
using a 40X 1.3 NA Zeiss Plan-Neofluar objective or 100X 1.4 NA
Zeiss Plan-Apochromat objective. The confocal pinhole was set at
1 Airy unit. Cells were maintained in phenol-red free DME
containing 10% fetal calf serum and 50 mM Hepes or EBSS
where indicated for live-cell imaging experiments. Cells were
imaged live at 22uC for quantification of N/C ratios or 37uC for
FRAP analysis using a stage heater and objective heater. EGFP
fluorescence was excited using the 488 nm line of a 40 mW Argon
laser, and mRFP and mStrawberry were excited at 543 nm of a
HeNe laser and detected using filter sets provided by the
manufacturer. For presentation purposes, images were exported
as TIFF files and contrast was adjusted using Adobe Photoshop.
For FRAP measurements of nuclear import and export, cells
were imaged using a 40X 1.3 NA Zeiss Plan-Neofluar objective at
3X digital zoom with the confocal pinhole set to 1 Airy unit.
Images were collected at 1% transmission with line averaging of 4.
For measurements of nuclear import, an oval completely filling the
nucleus was selected as the bleach region. For measurements of
nuclear export, the bleach region contained the cytoplasmic region
but excluded the nucleus. Photobleaching was accomplished by
transiently increasing the laser power to 100% and repetitively
scanning the bleach region either 10 (EGFP-LC3 and tfLC3) or 40
(EGFP) times. Images were collected every 5 s during the recovery
phase for measurements of nuclear import and every 5 s (for
EGFP) or 8 s (for EGFP-LC3, tfLC3) for measurements of nuclear
export.
FRAP measurements were performed at 37uC. For FRAP
measurements of lateral diffusion, cells were imaged using a 40X
1.3 NA Zeiss Plan-Neofluar objective at 4X digital zoom with the
confocal pinhole set to 1 Airy unit. For cells expressing EGFP, the
location of the nucleus was identified by focusing to the top of the
cell. Only the EGFP channel was imaged for cells expressing
tfLC3. Images were collected for a square region 70670 pixels
(7.84 mm67.84 mm). Photobleaching of a circular bleach region
25 pixels in diameter (2.75 mm) was performed by repetitively
scanning the bleach region 20 times using 100% laser power.
Images were collected every 0.14 s during the recovery phase for a
total of 16.75 s. Under the conditions of these experiments, no
overall photobleaching due to imaging was observed. For
presentation purposes, recovery curves from 5–7 cells from an
individual experiment were averaged.
Quantification of N/C ratios from confocal images
LSM images were exported as Tiff files and fluorescence
intensities in the nuclear and cytoplasmic regions were quantified
using Image J (http://rsbweb.nih.gov/ij/). Background-corrected
N/C ratios were calculated from mean fluorescence intensities
measured within a small square or circular region of interest
placed within the nucleus, cytoplasm, and outside of each cell.
Measurements of EGFP-LC3 in the cytoplasm were made in
regions of the cell devoid of punctate structures. Note that the
absolute N/C values varied somewhat between experiments
depending on exact imaging conditions and thus comparisons
were only made for paired experiments. Where indicated, N/C
data were normalized to control values for a given experiment to
enable comparison across different days.
FRAP analysis
To analyze the FRAP data, we used a modified form of the
Gaussian laser FRAP equation of Axelrod [60] that corrects for
diffusion of molecules during the photobleach [46]. The
theoretical basis for this approach is described elsewhere [61]. In
brief, in this approach, we used an experimentally determined
radius, re, obtained immediately after the photobleach, to calculate
diffusion coefficients. To measure re, the LSM 510 software was
used to calculate a pixel-wide line profile across the box containing
the bleaching spot. We averaged the intensities from 4 profile
measurements from each dataset. The intensity profiles were then
fit to a postbleach profile by the Gaussian laser to obtain the half
width at e
22 height of postbleach intensity distribution from
Fx ,y,0 ðÞ ~Fi exp {K exp {
2 x2zy2  
r2
e
     
ðeq:1Þ
Assuming rn # re, the following the calculation was performed as
described in [60]
Ft ðÞ ~
Fis
Ks cs ,K ðÞ ð eq:2Þ
where s~r2
e
 
8Dtzr2
n
  
and cs ,K ðÞ ~
ðK
0
us{1e{udu, the lower
incomplete gamma function. The bleaching parameter (K) was
computed from initial fluorescence intensity, F(0), by solving
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Note that when rn = re, then Eq. (1),(3) reduce to the
conventional FRAP formula as described in [60].
In some instances FRAP curves were analyzed individually then
the resulting D and Mf averaged, whereas for others data analysis
was performed on averaged FRAP curves collected from 10
different cells on a single day rather than individual recovery
curves to improve the signal to noise ratio [38]. Mobile fractions
were calculated as described previously [32].
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